Thu, Aug 21, 2014, 9:48 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

IntelliPharmaCeutics International Inc. Message Board

  • ms.wardcleaver ms.wardcleaver Apr 8, 2014 3:31 PM Flag

    Presentation was better than the one in March

    He did a better job of driving home the point that IPCI is not your typical generic copycat drug company. He really explained the Rexista technology very well and also strongly hinted that the Focalin revenue will be decent. I continue to hold my shares long term.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If revenues come in above $6M for the 1st qtr. we will be over $5. The higher the revenue number then we could see a more significant rise in the share price. They think revenues will continue after the 180 day exclusivity period as other future competitors may not be able to deliver the product leaving them with the market for some time and establishing themselves as the main supplier to the marketplace. Of course there are other announcements that could come as well. The end of the rotation out of biotech will end and maybe very soon, that will be another factor for the pps to rise.

      Sentiment: Strong Buy

    • Agree. . . seems like something is brewing regarding a Rexista partnership since he mentioned someone else's deal and said this is what we are expecting to kind of get.

      Sentiment: Strong Buy

2.470.00(0.00%)Aug 21 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.